Dr. Bruce Bloom is Chief Collaboration Officer of Healx, a Cambridge UK biotech using AI and drug redevelopment to create novel therapies for rare disease patients. He is the founder and former CEO of the global charity Cures Within Reach that brought over a dozen redeveloped drug therapies to patients through proof of concept clinical trials, and developed CureAccelerator®, the online drug redevelopment collaboration marketplace. Dr. Bloom is an Ashoka Social Entrepreneur Fellow, the Patient Advisory Board Chair for the Institute for Translational Medicine, board member of the Drug Discovery Center and Chair of the Cancer Center Advancement Advisory Boards at the University of Illinois Chicago, member of the Vanderbilt Institute for Clinical and Translational Research External Advisory Board, Executive Board member of Mission: Cure, and is on the Science Advisory Boards of Rediscovery Life Sciences, the Dr. Ralph and Marian Falk Medical Research Trust Awards Programs, the Findacure Fundamental Disease Charity, the Rare Disease Research Hub of the Westchester Biotech Project, OneThree Biotech, and ReBootRx, a member of the IRDiRC Working Group on Rare Disease Treatment Access and the editorial board of ASSAY and Drug Development Technologies.
Bruce Bloom
